ATOSSA THERAPEUTICS, INC. Common Stock, Value, Issued
ATOSSA THERAPEUTICS, INC. (ATOS) had Common Stock, Value, Issued of $1.80 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-07
- 2026-06-30: Common Stock, Value, Issued $1.80M.
- 2026-03-31: Common Stock, Value, Issued $1.55M.
- 2025-12-31: Common Stock, Value, Issued $1.55M.
- 2025-09-30: Common Stock, Value, Issued $23.49M.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $1.80M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.55M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.55M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $23.49M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $23.49M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $23.49M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.55M 10-K · filed 2026-03-25 | $23.49M 10-K · filed 2025-03-25 |
| 2024-09-30 | $22.88M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $22.87M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $22.83M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $22.79M 10-K · filed 2025-03-25 | |
| 2023-09-30 | $22.79M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $22.79M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $22.79M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $22.79M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $22.79M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $22.79M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $22.79M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $22.79M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $22.79M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $22.67M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $21.75M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $8.56M 10-K · filed 2022-02-28 | $8.56M 10-K · filed 2021-03-31 |
| 2020-09-30 | $1.88M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.67M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.64M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.64M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $1.64M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.64M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $1.64M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $1.05M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $994.17K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $877.33K 10-Q/A · filed 2018-11-13 | |
| 2018-03-31 | $477.34K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $477.34K 10-K · filed 2019-03-28 | |
| 2017-09-30 | $210.34K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $150.49K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $56.80K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $56.80K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $56.82K 10-Q/A · filed 2017-03-21 | |
| 2016-06-30 | $39.57K 10-Q/A · filed 2017-03-21 | |
| 2016-03-31 | $38.82K 10-Q/A · filed 2017-03-21 | |
| 2015-12-31 | $32.66K 10-K/A · filed 2017-03-21 | |
| 2015-09-30 | $30.45K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $29.05K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $27.22K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $24.56K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $24.56K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $24.44K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $24.43K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $18.57K 10-K · filed 2015-03-30 | |
| 2013-09-30 | $17.45K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $15.34K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $14.51K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $12.92K 10-K · filed 2014-03-27 | |
| 2012-09-30 | $12.12K 10-Q/A · filed 2013-01-22 | |
| 2011-12-31 | $11.26K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |